Header Logo

Mohit Chopra

Concepts (129)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cocaine-Related Disorders
4
2025
81
0.680
 Why?
Depressive Disorder
3
2009
284
0.680
 Why?
Stress Disorders, Post-Traumatic
3
2016
404
0.680
 Why?
Opioid-Related Disorders
5
2025
528
0.550
 Why?
Memantine
3
2014
22
0.550
 Why?
Methadone
3
2025
140
0.540
 Why?
Health Status
2
2016
447
0.450
 Why?
Excitatory Amino Acid Antagonists
2
2013
38
0.450
 Why?
Social Stigma
1
2016
78
0.440
 Why?
Obsessive-Compulsive Disorder
1
2011
35
0.350
 Why?
Benzodiazepines
1
2011
107
0.340
 Why?
Patient Acceptance of Health Care
1
2016
497
0.340
 Why?
Narcotics
2
2025
57
0.330
 Why?
Disulfiram
2
2025
5
0.310
 Why?
Alzheimer Disease
3
2014
765
0.300
 Why?
Quality of Life
2
2016
1259
0.300
 Why?
Apolipoprotein E4
1
2009
46
0.290
 Why?
Antipsychotic Agents
1
2011
303
0.290
 Why?
Methadyl Acetate
1
2008
1
0.290
 Why?
Reward
1
2009
89
0.290
 Why?
Psychiatric Status Rating Scales
2
2013
382
0.290
 Why?
Narcotic Antagonists
2
2014
133
0.280
 Why?
Naloxone
1
2008
53
0.280
 Why?
Buprenorphine
2
2014
198
0.260
 Why?
Cognition Disorders
1
2008
223
0.250
 Why?
Aging
1
2013
771
0.250
 Why?
Alcohol Deterrents
1
2025
6
0.230
 Why?
Geriatric Assessment
1
2006
161
0.220
 Why?
Dementia
1
2008
280
0.220
 Why?
Long-Term Care
1
2006
179
0.220
 Why?
Aged
12
2016
14963
0.210
 Why?
Male
19
2025
31055
0.200
 Why?
Opiate Substitution Treatment
3
2025
223
0.200
 Why?
Hallucinations
1
2003
17
0.190
 Why?
Depression
3
2016
900
0.190
 Why?
Vitamin E
2
2014
55
0.190
 Why?
Female
18
2025
34030
0.190
 Why?
Treatment Refusal
1
2003
58
0.190
 Why?
Mental Competency
1
2003
63
0.190
 Why?
Anxiety
3
2016
426
0.180
 Why?
Comorbidity
3
2016
1119
0.180
 Why?
Informed Consent
1
2003
141
0.180
 Why?
Antioxidants
2
2014
249
0.170
 Why?
Attitude to Health
1
2003
296
0.170
 Why?
Humans
21
2025
65141
0.150
 Why?
Nursing Homes
1
2006
686
0.150
 Why?
Decision Making
1
2003
418
0.150
 Why?
Double-Blind Method
6
2025
739
0.140
 Why?
Severity of Illness Index
5
2014
1559
0.130
 Why?
Veterans
3
2016
762
0.130
 Why?
Dose-Response Relationship, Drug
3
2025
856
0.130
 Why?
Cyclohexanecarboxylic Acids
1
2014
9
0.110
 Why?
Dopamine Agents
1
2014
11
0.100
 Why?
Amines
1
2014
31
0.100
 Why?
Sertraline
1
2014
58
0.100
 Why?
gamma-Aminobutyric Acid
1
2014
75
0.100
 Why?
Aged, 80 and over
4
2014
5614
0.100
 Why?
Alcohol-Related Disorders
1
2013
37
0.090
 Why?
Alcoholism
1
2016
327
0.090
 Why?
Adult
8
2025
17358
0.090
 Why?
Longitudinal Studies
2
2013
1282
0.090
 Why?
Motivation
1
2014
296
0.090
 Why?
Disease Progression
2
2014
1219
0.090
 Why?
Combat Disorders
1
2011
11
0.090
 Why?
Patient Compliance
2
2014
367
0.080
 Why?
Activities of Daily Living
2
2014
293
0.080
 Why?
Life Change Events
1
2011
66
0.080
 Why?
Internet
1
2014
468
0.080
 Why?
Wounds and Injuries
1
2013
250
0.080
 Why?
Amphetamine-Related Disorders
1
2009
11
0.080
 Why?
Chronic Disease
1
2013
742
0.080
 Why?
Methamphetamine
1
2009
25
0.080
 Why?
Directive Counseling
1
2009
39
0.070
 Why?
Arkansas
1
2008
4
0.070
 Why?
Benzhydryl Compounds
1
2009
61
0.070
 Why?
Logistic Models
2
2011
1270
0.070
 Why?
Cocaine
2
2025
101
0.070
 Why?
Secondary Prevention
1
2009
165
0.070
 Why?
United States
3
2013
8098
0.070
 Why?
Self Concept
1
2008
121
0.070
 Why?
Paroxetine
2
2004
16
0.070
 Why?
Substance Withdrawal Syndrome
1
2008
126
0.060
 Why?
Middle Aged
6
2025
18273
0.060
 Why?
Sex Characteristics
1
2008
214
0.060
 Why?
Neuropsychological Tests
1
2008
410
0.060
 Why?
Psychometrics
1
2008
392
0.060
 Why?
Multivariate Analysis
1
2008
930
0.060
 Why?
Mental Health Services
2
2011
304
0.060
 Why?
Dysthymic Disorder
1
2005
8
0.060
 Why?
Psychotherapy
1
2006
102
0.060
 Why?
Mortality
1
2006
161
0.050
 Why?
Pindolol
1
2004
2
0.050
 Why?
Prolactin
1
2004
40
0.050
 Why?
Antidepressive Agents
1
2006
233
0.050
 Why?
Antidepressive Agents, Second-Generation
1
2004
30
0.050
 Why?
Tryptophan
1
2004
56
0.050
 Why?
Disability Evaluation
1
2005
216
0.050
 Why?
Treatment Outcome
3
2025
5790
0.050
 Why?
Combined Modality Therapy
2
2014
372
0.050
 Why?
Adrenergic beta-Antagonists
1
2004
152
0.050
 Why?
Hydrocortisone
1
2004
192
0.050
 Why?
Drug Therapy, Combination
2
2014
463
0.050
 Why?
Cross-Sectional Studies
2
2011
2704
0.050
 Why?
Surveys and Questionnaires
1
2008
2763
0.040
 Why?
Follow-Up Studies
1
2005
2484
0.040
 Why?
Primary Health Care
1
2005
722
0.040
 Why?
Adolescent
1
2009
6306
0.030
 Why?
Remission Induction
2
2011
149
0.030
 Why?
Diagnostic and Statistical Manual of Mental Disorders
2
2011
118
0.030
 Why?
Retrospective Studies
1
2008
6865
0.030
 Why?
GABA Agonists
1
2014
4
0.030
 Why?
Diagnosis, Dual (Psychiatry)
1
2014
89
0.030
 Why?
Cross-Over Studies
2
2004
164
0.030
 Why?
Cholinesterase Inhibitors
1
2014
50
0.020
 Why?
Residence Characteristics
1
2014
230
0.020
 Why?
Medication Adherence
1
2014
199
0.020
 Why?
Recurrence
1
2014
657
0.020
 Why?
Risk Factors
2
2011
5430
0.020
 Why?
Caregivers
1
2014
293
0.020
 Why?
Analgesics, Opioid
1
2014
527
0.020
 Why?
Self Report
1
2010
391
0.020
 Why?
Sex Factors
1
2011
991
0.020
 Why?
Alcohol Drinking
1
2010
322
0.020
 Why?
Pilot Projects
1
2009
1016
0.010
 Why?
Mass Screening
1
2011
698
0.010
 Why?
Fluoxetine
1
2004
45
0.010
 Why?
Young Adult
1
2014
4812
0.010
 Why?
Drug Administration Schedule
1
2004
296
0.010
 Why?
Substance-Related Disorders
1
2011
755
0.010
 Why?
Chopra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (129)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_